Bradley A. Maron MD
Adjunct Instructor, Cardiovascular Medicine
Associate Professor, Medicine
72 E. Concord Street | (617) 638-5300bmaron@partners.org
Sections
Cardiovascular Medicine
Biography
Dr. Bradley Allen Maron is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH) and an assistant professor of medicine at Harvard Medical School (HMS). In addition, he serves as a co-director of the Pulmonary Vascular Disease Center at VA Boston Healthcare System.
He received his medical degree from The Warren Alpert Medical School of Brown University and completed an internal medicine residency at Boston Medical Center. He then completed cardiovascular medicine research and clinical fellowship programs at BWH.
Other Positions
Websites
Education
Medicine, MD, Brown University
Psychology, BA, Williams College
Publications
Kovacs G, Moutchia J, Zeder K, Maron BA, Al-Naamani N, Ventetuolo C, Olschewski H, Kawut SM. Clinical Response to PAH Treatment Does Not Depend on Pulmonary Artery Wedge Pressure - A Meta-Analysis Using Individual Participant Data from Randomized Clinical Trials. Am J Respir Crit Care Med. 2024 Jul 09. PMID: 38980192.
Published on 7/4/2024Weatherald J, Hemnes AR, Maron BA, Mielniczuk LM, Gerges C, Price LC, Hoeper MM, Humbert M. Phenotypes in Pulmonary Hypertension. Eur Respir J. 2024 Jul 04. PMID: 38964779.
Published on 7/4/2024Zeder K, Avian A, Mak S, Giannakoulas G, Kawut SM, Maron BA, Humbert M, Olschewski H, Kovacs G. Pulmonary Arterial Wedge Pressure in Healthy Subjects - a Meta-Analysis. Eur Respir J. 2024 Jul 04. PMID: 38964777.
Published on 7/4/2024Zeder K, Douschan P, Foris V, Sassmann T, Maron BA, Olschewski H, Kovacs G. The prognostic relevance of exercise pulmonary hypertension in cardiac and pulmonary diseases. Curr Opin Pulm Med. 2024 Jul 04. PMID: 38958564.
Published on 6/18/2024Zeder K, Siew ED, Kovacs G, Brittain EL, Maron BA. Pulmonary hypertension and chronic kidney disease: prevalence, pathophysiology and outcomes. Nat Rev Nephrol. 2024 Jun 18. PMID: 38890546.
Published on 6/17/2024Wyant GA, Jiang Q, Singh M, Qayyum S, Levrero C, Maron BA, Kaelin WG. Induction of DEPP1 by HIF Mediates Multiple Hallmarks of Ischemic Cardiomyopathy. Circulation. 2024 Jun 17. PMID: 38881449.
Published on 6/12/2024Lawrie A, Chin K, Fong YL, Gargano C, Gitton X, He C, Kiely DG, Zhou L, Zhou L, Maron BA, Quinn D, Rosenkranz S, Stamatiadis D, Toshner M, Wilkins MR, Howard L, Preston IR. Two prospective, multicenter studies for the identification of biomarker signatures for early detection of pulmonary hypertension (PH): The CIPHER and CIPHER-MRI studies. Pulm Circ. 2024 Apr; 14(2):e12386. PMID: 38868397.
Published on 5/20/2024Johnson SW, Wang RS, Winter MR, Gillmeyer KR, Zeder K, Klings ES, Goldstein RH, Wiener RS, Maron BA. Cluster analysis identifies novel real-world lung disease-pulmonary hypertension subphenotypes: implications for treatment response. ERJ Open Res. 2024 May; 10(3). PMID: 38770008.
Published on 5/15/2024Zeder K, Brittain E, Kovacs G, Maron BA. The Management of Mild Pulmonary Hypertension in Clinical Practice. Ann Am Thorac Soc. 2024 May 15. PMID: 38747696.
Published on 4/28/2024Ziehr DR, Li F, Parnell KM, Krah NM, Leahy KJ, Guillermier C, Varon J, Baron RM, Maron BA, Philp NJ, Hariri LP, Kim EY, Steinhauser ML, Knipe RS, Rutter J, Oldham WM. Lactate transport inhibition therapeutically reprograms fibroblast metabolism in experimental pulmonary fibrosis. bioRxiv. 2024 Apr 28. PMID: 38712233.